WuXi STA to buy Swiss pharma manufacturing facility from Bristol Myers Squibb
The Couvet site is a state-of-the-art manufacturing facility with commercial-scale capacity to produce capsule and tablet dosage forms. For WuXi STA, the Couvet site will be its first